$BPTH Balance Sheet | Understand Stock

$BPTH

$0.03 +$0.01 (71.33%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	Q1 FY2026 As of Mar 31, 2026	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021
Current assets
Cash
Cash
Prepaid drug product
Other current assets
Total current assets
Furniture, fixtures & equipment
Less accumulated depreciation
Fixed assets, net
Right of use operating assets
Total Assets
Accounts payable
Notes payable
Accrued expenses
Derivative liabilities
Lease liabilities
Total current liabilities
Warrant liability
Noncurrent lease liabilities
Total Liabilities
Preferred stock, $.001 par value; 10,000 shares authorized; 51 and 0 shares issued and outstanding, respectively
Common stock, $.001 par value; 200,000 shares authorized; 9,242 and 5,768 shares issued and outstanding, respectively
Common stock to be issued
Additional paid in capital
Accumulated deficit
Total shareholders' (deficit) equity
Total Liabilities & Shareholders' (Deficit) Equity

Comments